The exciting thing is that HeartSentry is a device that isnt culturally specific, like the Fitbit. Every hospital and clinic throughout the world will need one
I'm just glad to see that this still has more green days than red, even when investors are selling themselves short. As for the future PPS? Once this goes to market, it will perform very well, I mean, why would it not
News 
Market Data 
Discover 
